Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity
JHW Pahl, SEN Ruslan, KMC Kwappenberg… - Cancer Immunology …, 2013 - Springer
Osteosarcoma and Ewing's sarcoma tumor cells are susceptible to IL15-induced or antibody-
mediated cytolytic activity of NK cells in short-term cytotoxicity assays. When encountering …
mediated cytolytic activity of NK cells in short-term cytotoxicity assays. When encountering …
Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms
LR Soldi, VLC Silva, DH Rabelo, IA Uehara… - Journal of Cancer …, 2023 - Springer
Natural killer cells are critical players in the antitumor immune response due to their ability to
destroy target cells through cytotoxic activity and other means. However, this response is …
destroy target cells through cytotoxic activity and other means. However, this response is …
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
EP Buddingh, MW Schilham, SEN Ruslan… - Cancer immunology …, 2011 - Springer
High-grade osteosarcoma occurs predominantly in adolescents and young adults and has
an overall survival rate of about 60%, despite chemotherapy and surgery. Therefore, novel …
an overall survival rate of about 60%, despite chemotherapy and surgery. Therefore, novel …
Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and …
CJ Voskens, R Watanabe, S Rollins… - Journal of Experimental …, 2010 - Springer
Background The possibility that autologous NK cells could serve as an effective treatment
modality for solid tumors has long been considered. However, implementation is hampered …
modality for solid tumors has long been considered. However, implementation is hampered …
Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors
We provide evidence that tumor cells can induce apoptosis of NK cells by engaging the
natural cytotoxicity receptors (NCR) NKp30, NKp44, and NKp46. Indeed, the binding …
natural cytotoxicity receptors (NCR) NKp30, NKp44, and NKp46. Indeed, the binding …
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
DHJ Verhoeven, ASK de Hooge, ECK Mooiman… - Molecular …, 2008 - Elsevier
INTRODUCTION: Ewing sarcoma (EWS) is a malignant bone-associated sarcoma, with poor
prognosis in case of metastasis or relapse. To explore the feasibility of natural killer (NK) cell …
prognosis in case of metastasis or relapse. To explore the feasibility of natural killer (NK) cell …
NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies
G Fregni, A Perier, MF Avril, A Caignard - Oncoimmunology, 2012 - Taylor & Francis
The recent findings on NK activation indicate that these cells are important antitumor
effectors. NK cells participate in the graft-vs.-leukemia effect to control the relapse in …
effectors. NK cells participate in the graft-vs.-leukemia effect to control the relapse in …
NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy?
Natural killer (NK) cells exert potent antitumor activity. However, NK cells infiltrating solid
tumors are severely impaired in their function. Remarkably, NK cells isolated from malignant …
tumors are severely impaired in their function. Remarkably, NK cells isolated from malignant …
Cutting edge: tumor-targeting antibodies enhance NKG2D-mediated NK cell cytotoxicity by stabilizing NK cell–tumor cell interactions
Monoclonal antibodies represent a promising approach to fight a variety of tumors, but their
mode of action remains to be fully understood. NK cells can recognize Ab-coated targets, as …
mode of action remains to be fully understood. NK cells can recognize Ab-coated targets, as …
Prospects for NK cell therapy of sarcoma
Simple Summary Sarcomas are a group of aggressive tumors originating from mesenchymal
tissues. Patients with advanced disease have poor prognosis due to the ineffectiveness of …
tissues. Patients with advanced disease have poor prognosis due to the ineffectiveness of …